EQS-Adhoc: Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot


Werte in diesem Artikel
Aktien

89.66 EUR -1.12 EUR -1.23 %

EQS-Ad-hoc: Symrise AG / Key word(s): Personnel
Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot

29-Feb-2024 / 12:23 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


Holzminden, 29 February 2024
CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot
Dr Jean-Yves Parisot will become CEO of Symrise AG, effective end of 31 March 2024. This has been decided by the company's Supervisory Board in its meeting today. The Supervisory Board has also renewed the contract of Dr Jean-Yves Parisot for another four years until the end of September 2028.
Dr Jean-Yves Parisot has been a member of the Executive Board of Symrise AG since 2016, being responsible for the Taste, Nutrition & Health segment. He takes over as CEO from Dr Heinz-Jürgen Bertram, whose contract originally would have expired by end of October 2025 and who is now retiring in the best mutual consent and agreement. He will continue to work closely with Dr Jean-Yves Parisot to ensure a smooth handover.
www.symrise.com
Media contact:                                                  Investor Relations contact:
Bernhard Kott                                                 Tobias Erfurth
Tel.: +49 55 31 90-17 21                                   Tel.: +49 55 31 90-1879
Email: bernhard.kott@symrise.com                   Email: Tobias.Erfurth@symrise.com


End of Inside Information

29-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: ir@symrise.com
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1848477

 
End of Announcement EQS News Service

Werbung

1848477  29-Feb-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1848477&application_name=news&site_id=smarthouse

Aktuelle Symrise Aktie News

Werbung

Symrise Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Symrise nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
02.07.26 Symrise Buy Deutsche Bank AG
29.06.26 Symrise Equal Weight Barclays Capital
18.06.26 Symrise Buy UBS AG
09.06.26 Symrise Overweight JP Morgan Chase & Co.
08.06.26 Symrise Neutral Goldman Sachs Group Inc.